Browsing: Biocon

1 month ago

1 month ago BIOCON Board to Consider Fundraising Options on April 23

2 months ago

2 months ago Biocon Subsidiary Secures US FDA Approval for Everolimus Tablets

3 months ago

3 months ago Biocon Launches Liraglutide (GLP-1) in the UK: Expanding Diabetes Portfolio

4 months ago

4 months ago Biocon Expects Strong Growth in Q4FY25 and Beyond

4 months ago Biocon to Issue ₹570 Crore in Commercial Papers

4 months ago Biocon to Explore Fundraising Options on January 27th

5 months ago

5 months ago Biocon Biologics’ Malaysian Facility Receives VAI Classification from US FDA

5 months ago Biocon Biologics Receives Approval for Ustekinumab Biosimilar in Japan

5 months ago Biocon Receives USFDA EIR with Voluntary Action Indicated Status for Bengaluru Facility

5 months ago Biocon Wins FDA Approval for Generic Versions of Victoza and Saxenda